Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023)Review Published on 2024-08-022024-09-05 Journal: Vaccines [Category] update2024, [키워드] patents subunit Tuberculosis Vaccine Viral vector [DOI] 10.3390/vaccines12080876 PMC 바로가기 [Article Type] Review
Sorry you asked? Mayo, Myriad , and the battles over patent-eligibilityOriginal Article Published on 2024-06-042024-09-05 Journal: Journal of Law and the Biosciences [Category] update2024, [키워드] coverage and reimbursement Genetic testing Inherited risk of cancer molecular diagnostics patents [DOI] 10.1093/jlb/lsae010 PMC 바로가기 [Article Type] Original Article
Do weak institutions undermine global innovation production efficiency?Article Published on 2023-03-072024-09-05 Journal: The Journal of Technology Transfer [Category] update2024, [키워드] C20 corruption Efficiency Government Innovation institutions K42 knowledge O31 O33 patents Regulatory quality State fragility Stochastic frontier analysis Uncertainty [DOI] 10.1007/s10961-023-09997-7 PMC 바로가기 [Article Type] Article
Transfer of parasitology research to patents worldwidearticle Published on 2022-08-312024-09-01 Journal: Family process [Category] 말라리아, [키워드] Parasitology patents R&D SciVal Scopus [Article Type] article
Premarket Development Times for Innovative Vaccines–To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?article Published on 2022-01-292024-09-02 Journal: Clinical infectious diseases : an official publication of the Infectious [Category] 대상포진, [키워드] BNT162b2 ChAdOx1-S COVID-19 vaccines development time mRNA-1273 patents Vaccine development Vaccine hesitancy Vaccines [DOI] 10.1093/cid/ciab389 PMC 바로가기 [Article Type] article
The latest developments in the area of therapeutic delivery excluding some diseases, such as COVID-19 and the big three (HIV/AID, malaria and tuberculosis)Covid-19 및 Big Three (HIV/AID, Malaria 및 Tuberculosis)와 같은 일부 질병을 제외한 치료 전달 분야의 최신 발전Industry News Published on 2021-10-212022-08-31 Journal: Therapeutic Delivery [Category] MERS, SARS, 말라리아, 치료제, [키워드] Analysis approval approvals Cancer cardiovascular diseases Care COVID-19 COVID-19 research Critical disease develop Diseases drug candidate example Final flavonoids group growth gut microbioma Health Health care healthcare imperative indication malaria new approvals nutrition and health orphan medicines other disease other diseases patents Pompe disease press public opinion raised rare disease rare diseases Regulatory Release Research research and development researcher severe atopic dermatitis severe plaque psoriasis systemic lupus erythematosus therapeutic therapy Tuberculosis von Hippel-Lindau disease Waldenström's macroglobulinemia website Wilson disease [DOI] 10.4155/tde-2021-0066 PMC 바로가기 [Article Type] Industry News
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19Molnupiravir에 대한 발견, 개발 및 특허 동향: COVID-19에 대한 유망한 경구 치료제Review Published on 2021-09-242022-09-10 Journal: Molecules [Category] SARS, 임상, 치료제, [키워드] Baricitinib Clinical data clinical trial Combination COVID-19 COVID-19 pandemic demonstrated develop development disease dosage drug effective EIDD-1931 EIDD-2801 Favipiravir forms humans Influenza inhalers market meet MK-4482 molnupiravir oral oral bioavailability pandemic Patent patents Patient pharmaceutical industry Phase 3 phase 3 clinical trial present Prospective RdRP RdRp inhibitor Remdesivir researcher Safe safety profile SARS-CoV-2 Tolerability tolerable treat Treatment treatment of influenza treatments for COVID-19 trend university USA variety viruses [DOI] 10.3390/molecules26195795 PMC 바로가기 [Article Type] Review
Current and Emerging Antivirals for the Treatment of Cytomegalovirus (CMV) Retinitis: an Update on Recent PatentsArticle Published on 2015-04-162024-09-04 Journal: Recent Patents on Anti-Infective Drug Discovery [Category] 대상포진, [키워드] antivirals cytomegalovirus patents Retinitis Therapeutics Treatment PMC 바로가기 [Article Type] Article